Antibody Technologies market research reports by DelveInsight

• Cancer Monoclonal Antibodies - Market Insights, Competitive Landscape, and Market Forecast - 2030

  Aug 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Cancer Monoclonal Antibodies - Market Insights, Competitive Landscape, and Market Forecast - 2030 Cancer Monoclonal Antibodies Market by Type (Humanized Antibodies, Chimeric Antibodies, Murine Antibodies), Application (Blood Cancer, Breast Cancer, Liver Cancer, Colorectal Cancer, and Others), End-Us ... Read More

• Plasma Protein Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  Aug 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Plasma Protein Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030 Plasma Protein Therapeutics Market by Product (Immunoglobulin, Albumin, Plasma Derived Factor VIII, and Others), Application (Hemophilia, Idiopathic Thrombocytopenic, Primary Immunodeficiencies, and Othe ... Read More

• Antibody Drug Conjugate - Market Insights, Competitive Landscape, and Market Forecast - 2030

  Jul 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Antibody Drug Conjugate - Market Insights, Competitive Landscape, and Market Forecast - 2030 Antibody Drug Conjugate Market By Cancer Type (Breast Cancer, Lung Cancer, Bladder Cancer, Brain Tumor, And Others), Target Type (CD19, HER2, CD22, And Others), End-User (Hospitals And Specialty Cancer Cente ... Read More

• Biopharmaceuticals Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030

  Jul 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Biopharmaceuticals Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030 Biopharmaceuticals Contract Manufacturing Market by Product (Biologics [Monoclonal Antibodies (MABs), Proteins/Peptides, Vaccines, and Others], Biosimilar), Source (Mammalian and Non-Mammal ... Read More

• Intravenous Immunoglobulin – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Intravenous Immunoglobulin – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Intravenous Immunoglobulin – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Intravenous Immunoglobulin, historical and forecasted epide ... Read More

• Antibody-Mediated Graft Rejection – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Antibody-Mediated Graft Rejection – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Antibody-Mediated Graft Rejection – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Antibody-Mediated Graft Rejection, historical ... Read More

• Anti-CD80 Antibody - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anti-CD80 Antibody - Pipeline Insight, 2024 “Anti-CD80 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD80 Antibody development. The report provides detailed coverage o ... Read More

• Antibody-Mediated Graft Rejection - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Antibody-Mediated Graft Rejection - Pipeline Insight, 2024 Antibody-Mediated Graft Rejection Overview ""Antibody-Mediated Graft Rejection Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Antibody-M ... Read More

• Anti-CD37 Antibody - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anti-CD37 Antibody - Pipeline Insight, 2024 “Anti-CD37 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD37 Antibody development. The report provides detailed coverage o ... Read More

• Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2024 “Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Dickkopf-1 (Dkk-1) Antibody developmen ... Read More

• Anti-CD152 Antibody - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anti-CD152 Antibody - Pipeline Insight, 2024 “Anti-CD152 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD152 Antibody development. The report provides detailed coverag ... Read More

• Myasthenia Gravis - Market Insight, Epidemiology And Market Forecast - 2034

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Myasthenia Gravis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The main treatment options for ALL include chemotherapy, targeted therapy, immunotherapy, surgery, radiation therapy, and stem cell transplant. In the last few years, immunotherapy has undergone a new phase of ... Read More

• Anti GM-CSF Antibody - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anti GM-CSF Antibody - Pipeline Insight, 2024 “Anti GM-CSF Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti GM-CSF Antibody development. The report provides detailed cove ... Read More

• Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2024 “Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Mucin 1 (MUC1) Antibody development. The repor ... Read More

• Anti-CD19 Antibody - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anti-CD19 Antibody - Pipeline Insight, 2024 “Anti-CD19 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD19 Antibody development. The report provides detailed coverage o ... Read More

• Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024 “Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD274 (PD-L1) Antibody development. The report p ... Read More

• Anti-CD52 Antibody - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anti-CD52 Antibody - Pipeline Insight, 2024 “Anti-CD52 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD52 Antibody development. The report provides detailed coverage o ... Read More

• Anti-CD3 Antibody - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Anti-CD3 Antibody - Pipeline Insight, 2024 “Anti-CD3 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD3 Antibody development. The report provides detailed coverage of t ... Read More

• Anti-CD33 Antibody - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anti-CD33 Antibody - Pipeline Insight, 2024 “Anti-CD33 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD33 Antibody development. The report provides detailed coverage o ... Read More

• Anti-CD28 Antibody - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anti-CD28 Antibody - Pipeline Insight, 2024 “Anti-CD28 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD28 Antibody development. The report provides detailed coverage o ... Read More

• Anti-CD38 antibody- Pipeline Insight, 2023

  Nov 01, 2023  |  Published by: DelveInsight  |  USD 1,500

  Anti-CD38 antibody- Pipeline Insight, 2023 DelveInsight’s, “Anti-CD38 antibody- Pipeline Insight, 2023” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Anti-CD38 antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical ... Read More

• Antibody Drug Conjugate- Competitive landscape, 2023

  Nov 01, 2023  |  Published by: DelveInsight  |  USD 5,000

  Antibody Drug Conjugate- Competitive landscape, 2023 DelveInsight’s, “Antibody Drug Conjugate- Competitive landscape, 2023,” report provides comprehensive insights about 180+ companies and 290+ drugs in Antibody Drug Conjugate Competitive landscape. It covers the therapeutics assessment by product t ... Read More

• Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - Market Insight, Epidemiology And Market Forecast - 2032

  Jul 01, 2023  |  Published by: DelveInsight  |  USD 7,500

  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Anti-neutrophilic cytoplasmic antibody (ANCA) associated vasculitis is a heterogeneous group of rare autoimmune conditions. ANCA Associated Vasculitis includes three ma ... Read More

• Monoclonal antibodies - Competitive landscape, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 5,000

  Monoclonal antibodies - Competitive landscape, 2023 DelveInsight’s, “Monoclonal antibodies - Competitive landscape, 2023,” report provides comprehensive insights about 180+ companies and 230+ drugs in Monoclonal antibodies Competitive landscape. It covers the therapeutics assessment by product type ... Read More

• Bispecific antibody - Competitive landscape, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 5,000

  Bispecific antibody - Competitive landscape, 2023 DelveInsight’s, “Bispecific antibody - Competitive landscape, 2023,” report provides comprehensive insights about 250+ companies and 300+ drugs in Bispecific antibody Competitive landscape. It covers the therapeutics assessment by product type, stage ... Read More

< prev 1 2 3 next >